Nutrition Intervention to Address Anemia Among Adolescent Girls in Liberia

Sponsor
Boston Children's Hospital (Other)
Overall Status
Withdrawn
CT.gov ID
NCT05073562
Collaborator
UNICEF (Other), Ministry of Health, Liberia (Other), Liberia Institute of Statistics and Geo-Information Services (Other)
0
2
2

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the feasibility and effectiveness of weekly iron and folic acid (IFA) supplementation and one-time deworming treatment at the community level in improving hemoglobin levels among adolescent girls in Liberia, West Africa, and to assess the feasibility and effectiveness of a targeted nutrition education program in improving nutrition knowledge, attitudes, and practices in the same population.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Iron and folic acid (IFA) supplementation
  • Behavioral: Targeted nutrition education
  • Drug: Mebendazole Pill
  • Other: Standard nutrition services
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
A Study on the Effectiveness of IFA Supplementation, Deworming, and Nutrition Education in Addressing Anemia Among Adolescent Girls in Two Counties in Liberia
Anticipated Study Start Date :
Oct 1, 2021
Anticipated Primary Completion Date :
Dec 1, 2021
Anticipated Study Completion Date :
Dec 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Nutrition+ Intervention

This group will receive a structured nutrition education package provided by Community Health Assistants (CHAs) based on a handbook on nutrition education developed by UNICEF with collaboration from the Liberia Ministry of Health. The structured nutrition education package will focus on four key areas: causes and prevention of anemia, healthy eating and food choices, hand washing, and physical exercise. Participants in the intervention group will also receive IFA supplementation on a weekly basis for the duration of the study, and a one-time oral deworming treatment (mebendazole), which will be administered once at the beginning of the study.

Dietary Supplement: Iron and folic acid (IFA) supplementation
Weekly IFA supplementation for duration of the study.

Behavioral: Targeted nutrition education
Structured nutrition education package delivered at household level by trained Community Health Assistants (CHAs)

Drug: Mebendazole Pill
One-time deworming treatment with mebendazole.

Active Comparator: Control group - standard services only

This group will receive only the current package of basic nutrition services provided at the health facility and at community level by health workers and CHAs, respectively.

Other: Standard nutrition services
Basic nutrition services currently provided at the health facility and at community level in Liberia

Outcome Measures

Primary Outcome Measures

  1. Change in participants' hemoglobin level from enrollment to completion of the study [Baseline and Week 12]

    Point of care hemoglobin testing will be conducted at enrollment and at the conclusion of the study.

Secondary Outcome Measures

  1. Changes in responses to questions in the Nutrition Knowledge, Attitudes, and Practice (KAP) survey from baseline to follow up evaluation [Baseline and Week 12]

    Increase in nutrition-related knowledge, and improvements in nutrition practices as evidenced by changes in responses to the KAP survey, which is based on validated measures of nutrition-related knowledge, attitudes, and practices, and has been modified for appropriateness to the target population of this study.

  2. Feasibility of targeted intervention for scale-up to country-wide enhanced nutrition services [12 weeks]

    Successful completion of study visits by Community Health Assistants, specifically ability to conduct every scheduled visit without skipping visits or households, within the timeframe of scheduled work day.

Eligibility Criteria

Criteria

Ages Eligible for Study:
10 Years to 19 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adolescent girl aged 10 - 19 years at the time of enrollment

  • Lives within the selected study communities in Montserrado or Margibi counties

  • Caregiver/adolescent consents to participate in the study

Exclusion Criteria:
  • Currently pregnant

  • Active malaria infection as defined by positive rapid diagnostic test (RDT)

  • Severe acute malnutrition at the time of enrollment

  • Known malignancy

  • Known sickle cell disease

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Boston Children's Hospital
  • UNICEF
  • Ministry of Health, Liberia
  • Liberia Institute of Statistics and Geo-Information Services

Investigators

  • Principal Investigator: Julia Rubin-Smith, MD, MSPH, Boston Children's Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Julia Rubin-Smith, Global Health Faculty/Assistant in Medicine, Boston Children's Hospital
ClinicalTrials.gov Identifier:
NCT05073562
Other Study ID Numbers:
  • P00036604
First Posted:
Oct 11, 2021
Last Update Posted:
Nov 22, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 22, 2021